Article

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression

2019-05-27

Abstract excerpt

<h4>Summary</h4> Immunotherapy is a treatment for many types of cancer, primarily due to deep and durable clinical responses mediated by immune checkpoint blockade (ICB) 1, 2 . Prostate cancer is a notable exception in that it is generally unresponsive to ICB. The standard treatment for advanced prostate cancer is androgen-deprivation therapy (ADT), a form of castration (CTX). ADT is initially effective, but ove...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ab7d6ffc-4266-583c-a402-d42607d8f99d
DOI: 10.1101/651083

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer ProgressionDOI 10.1101/651083Read

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.Semantic proximity Read

Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays Resistance to Androgen Deprivation TherapySemantic proximity Read

Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.Semantic proximity Read

Spatiotemporal profiling reveals the role of inflammatory niche in driving prostate cancerSemantic proximity Read

New approaches and prospects of immunotherapy and gene therapy for prostate cancerSemantic proximity Read

Correlation between high ratio of circulating PMN-MDSCs and poor prognosis in metastatic hormone sensitive prostate cancerSemantic proximity Read

Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancerSemantic proximity Read

WITHDRAWN: GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunitySemantic proximity Read

Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies.Semantic proximity Read

The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancerSemantic proximity Read

Prioritization of prostate cancer to immune checkpoint therapy by ranking tumors along IFN-γ axis and identification of immune resistance mechanismsSemantic proximity Read

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy predictionSemantic proximity Read